Machine Learning

A new AI-powered screening system at LaGuardia's Terminal B promises frictionless security, but can the tech firm behind it balance growth with finances?

A new partnership between biotech leader Debut and Amazonian expert Natura aims to revolutionize anti-aging skincare with AI-discovered ingredients.

A new survey reveals 4 in 5 tech leaders feel pressured to exaggerate AI success, creating a trillion-dollar paradox of high spending and low returns.

As AI speeds up coding, quality suffers. Checksum's new autonomous agent generates and self-heals tests to close the gap without human intervention.

With a new CCO known for creating unicorns, Ideon Technologies aims to revolutionize mining with subsurface imaging powered by particles from deep space.

The revived MoviePass partners with 5,000 independent theaters, a landmark deal that could save local cinemas and secure the subscription service's future.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

A new partnership between TD2 Oncology and Panome Bio aims to merge clinical expertise with deep multi-omics data to accelerate personalized cancer therapies.

With CHF 105 million in new funding, NUCLIDIUM is advancing its novel copper-based radiotheranostics for metastatic prostate and breast cancer.

This year's Shaw Prize honors scientists who turned a deadly leukemia into a curable disease and unraveled the secrets of stellar explosions.

Industrial firms can see cyber threats but struggle to act. TXOne Networks' new strategy aims to shift OT security from visibility to safe execution.

Ocean data startup Coastal Measures secures $260K from Maine Angels, establishing its Kittery HQ and bolstering Maine's role as a climate tech hub.

A landmark partnership between Certis and IntBot aims to deploy socially intelligent humanoid robots across Singapore, heralding a new era of human-robot collaboration.

John Theurer Cancer Center presents breakthroughs in CAR-T, ADCs, and health equity at ASCO, offering new hope for patients worldwide.

Prezent Vivo and Nested Knowledge partner to close the 'insight-to-action' gap, delivering AI-powered intelligence to pharma teams at unprecedented speed.

Two top executives at nonprofit Riverside Research are up for major awards, signaling a powerful new model for national security innovation.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

An upcoming tech event has drawn nearly 20,000 retailers, revealing a desperate need to fix broken, manual contract processes with AI technology.

With new funding from Bregal Sagemount, LSPedia is set to advance its AI tools, moving beyond compliance to build a smarter, safer pharma supply chain.

ValGenesis's upcoming event explores AI's pivotal role in pharma validation, charting a course from digital systems to intelligent, compliant operations.